Economic Burden of Reported Lyme Disease in High-Incidence Areas, United States, 2014-2016.

ABSTRACT: Approximately 476,000 cases of Lyme disease are diagnosed in the United States annually, yet comprehensive economic evaluations are lacking. In a prospective study among reported cases in Lyme disease-endemic states, we estimated the total patient cost and total societal cost of the disease. In addition, we evaluated disease and demographic factors associated with total societal cost. Participants had a mean patient cost of ≈$1,200 (median $240) and a mean societal cost of ≈$2,000 (median $700). Patients with confirmed disseminated disease or probable disease had approximately double the societal cost of those with confirmed localized disease. The annual, aggregate cost of diagnosed Lyme disease could be $345-968 million (2016 US dollars) to US society. Our findings emphasize the importanc

SUBMITTER: Hook SA 

PROVIDER: S-EPMC9155891 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature